TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 2 | 9 | 2 | -1 | -8 | -21 | -24 | -7 |
| S | %wins | 0 | 0 | 50 | 50 | 100 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/4/20 16:25 | 6/3/20 | CRTX | Cortexyme, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pfizer Inc | NY | T | S | -14,867 | 40.18 | 0 | -370 | -11 | 2,880 | D | |||||||||||||||
11/16/18 16:50 | 11/15/18 | ICUI | Icu Medical Inc/de | DE | Health | Drug | Pharmaceutical Preparations | Pfizer Inc | NY | D | S | -523,125 | 209.25 | 0 | -2,500 | -100 | 0 | I | |||||||||||||||
8/15/18 16:33 | 8/13/18 | ICUI | Icu Medical Inc/de | DE | Health | Drug | Pharmaceutical Preparations | Pfizer Inc | NY | DT | S | -199,045 | 284.35 | 0 | -700 | -22 | 2,500 | I | |||||||||||||||
8/12/15 16:30 | 8/10/15 | AQXP | Aquinox Pharmaceuticals, Inc | DE | Health | Drug | Pharmaceutical Preparations | Pfizer Inc | NY | T | S | -6,880 | 26.47 | 33 | -260 | -21 | 975 | D | 178 | 94 | 170 | 203 | 999 | 999 | 999 | 16 | 3 | -5 | -18 | -37 | -40 | ||
2/8/13 16:19 | 2/6/13 | ZTS | Zoetis Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pfizer Inc | NY | DT | S.d | 0 | 0.00 | 33 | -99,015 | -100 | 0 | D | 3 | 1 | 1 | 4 | 2 | -5 | -7 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |